Home / Inspections / 1024416

FDA Inspection 1024416 — XTANT Medical Holdings, Inc

XTANT Medical Holdings, Inc — FEI 3005031160

The FDA completed an inspection of XTANT Medical Holdings, Inc on August 21, 2017 in Belgrade, MT. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 21, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Belgrade, MT (United States)

Facility

Other inspections at this facility

  • 1149034 (NAI Fri Aug 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1026635 (NAI Fri Aug 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 969771 (NAI Wed May 18 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 876734 (NAI Thu May 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 843894 (VAI Fri Aug 02 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources